GPGrossPatternRESEARCH SYSTEM
SEC CHECK OPERATIONAL
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME

OFIX · Jun 30, 2024

Orthofix Medical Inc.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.

STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration

State dimensions

Filing0000950170-24-091200General Corporate
Debt relative to revenueRAWCurrent state valid · history insufficient
Evidence method

Level · gp.fundamentals.debt_to_revenue

59.41% · OPTIONAL · NOT_ENOUGH_HISTORY

Capex intensityRAWCurrent state valid · history insufficient
Evidence method

Level · gp.fundamentals.capex_revenue_ratio

4.70% · OPTIONAL · NOT_ENOUGH_HISTORY

Operating cash generationRAWCurrent state valid · history insufficient
Evidence method

Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue

4.52% · OPTIONAL · NOT_ENOUGH_HISTORY

Inventory pressureRAWCurrent state valid · history insufficient
Evidence method

Level · gp.fundamentals.inventory_revenue_ratio

105.75% · OPTIONAL · NOT_ENOUGH_HISTORY

Gross marginRAWCurrent state valid · history insufficient
Evidence method

Level · gp.fundamentals.gross_margin

67.84% · CORE · NOT_ENOUGH_HISTORY

Operating marginRAWCurrent state valid · history insufficient
Evidence method

Level · gp.fundamentals.operating_margin

-12.54% · CORE · NOT_ENOUGH_HISTORY

R&D intensityRAWCurrent state valid · history insufficient
Evidence method

Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue

9.09% · OPTIONAL · NOT_ENOUGH_HISTORY

SBC intensityRAWCurrent state valid · history insufficient
Evidence method

Level · gp.fundamentals.sbc_revenue_ratio

5.01% · OPTIONAL · NOT_ENOUGH_HISTORY

As-filed lineage

Fundamental state history

Each observation is tied to the filing and facts available at that report date. Amendments remain separate.

History10 statesHistory building
Mar 31, 20240/8 normalizedLevel 3Jun 30, 20240/8 normalizedLevel 3Sep 30, 20240/8 normalizedLevel 3Dec 31, 20240/8 normalizedLevel 3Mar 31, 20250/9 normalizedLevel 3Jun 30, 20250/9 normalizedLevel 3Sep 30, 20250/9 normalizedLevel 3Dec 31, 20250/9 normalizedLevel 3Mar 31, 20267/8 normalizedLevel 3Jun 30, 20267/8 normalizedLevel 3
Period transition

What moved in the state?

Balance Sheet Leverage Decreased
Previous
62.67%
Current
59.41%
Delta
-3.26%
Capex Intensity Decreased
Previous
5.59%
Current
4.70%
Delta
-0.89%
Cash Generation Increased
Previous
-9.86%
Current
4.52%
Delta
14.38%
Inventory Pressure Decreased
Previous
116.15%
Current
105.75%
Delta
-10.40%
Margin Increased
Previous
67.46%
Current
67.84%
Delta
0.38%
Profitability Increased
Previous
-15.55%
Current
-12.54%
Delta
3.01%
R And D Intensity Decreased
Previous
10.33%
Current
9.09%
Delta
-1.25%
Sbc Intensity Increased
Previous
4.67%
Current
5.01%
Delta
0.35%
Self-history only

Previous similar states

Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.

Not enough compatible prior states for a transparent self-history match.
Research Graph

Related governed research

Transitioned To · OFIX Fundamental State →Has State · Orthofix Medical Inc. →Transitioned To · OFIX Fundamental State →Transitioned To · OFIX BALANCE_SHEET_LEVERAGE_DECREASED →Transitioned To · OFIX CAPEX_INTENSITY_DECREASED →Transitioned To · OFIX CASH_GENERATION_INCREASED →Transitioned To · OFIX INVENTORY_PRESSURE_DECREASED →Transitioned To · OFIX MARGIN_INCREASED →Transitioned To · OFIX PROFITABILITY_INCREASED →Transitioned To · OFIX R_AND_D_INTENSITY_DECREASED →Transitioned To · OFIX SBC_INTENSITY_INCREASED →

Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.